Forty-six patients with severe alcoholic hepatitis were prospectively randomized in an open study to standard medical therapy ( SMT ) plus G-CSF ( group A ; n = 23 ) at a dose of 5g/kg subcutaneously every 12h for 5 consecutive days or to SMT alone ( group B ; n = 23 ) at a tertiary care center .